Selected research
Industry Growth & Trends
Global Syndromic Diagnostic Test Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Syndromic Diagnostic Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Syndromic Diagnostic Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Syndromic Diagnostic Test market include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Syndromic Diagnostic Test market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Syndromic Diagnostic Test market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Syndromic Diagnostic Test market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Syndromic Diagnostic Test.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Syndromic Diagnostic Test market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Syndromic Diagnostic Test Market by Company
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Syndromic Diagnostic Test Segment by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Syndromic Diagnostic Test Segment by Application
Hospital
Laboratory
Research Institution
Others
Syndromic Diagnostic Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Syndromic Diagnostic Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Syndromic Diagnostic Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Syndromic Diagnostic Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Syndromic Diagnostic Test companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Extraction Test
- Polymerase Chain Reaction (PCR) Test
- Others
Applications
- Hospital
- Laboratory
- Research Institution
- Others
Companies covered
- Abbott
- Hologic
- Applied BioCode
- Danaher
- Diagenode
- Curetis
- Bio-Rad
- DiaSorin
- bioMérieux
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Syndromic Diagnostic Test Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Syndromic Diagnostic Test Market Size by Region (2021-2032)
- 1.4.1 Global Syndromic Diagnostic Test Market Size by Region (2021-2026)
- 1.4.2 Global Syndromic Diagnostic Test Market Size by Region (2027-2032)
- 1.5 Key Regions Syndromic Diagnostic Test Market Size (2021-2032)
- 1.5.1 North America Syndromic Diagnostic Test Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Syndromic Diagnostic Test Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Syndromic Diagnostic Test Market Size Growth Rate (2021-2032)
- 1.5.4 South America Syndromic Diagnostic Test Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Syndromic Diagnostic Test Market Size Growth Rate (2021-2032)
2 Syndromic Diagnostic Test Market by Type
- 2.1 Type Introduction
- 2.1.1 Nucleic Acid Extraction Test
- 2.1.2 Polymerase Chain Reaction (PCR) Test
- 2.1.3 Others
- 2.2 Global Syndromic Diagnostic Test Market Size by Type
- 2.2.1 Global Syndromic Diagnostic Test Market Size Overview by Type (2021-2032)
- 2.2.2 Global Syndromic Diagnostic Test Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Syndromic Diagnostic Test Market Size Forecasted by Type (2027-2032)
- 2.3 Global Syndromic Diagnostic Test Market Size by Regions
- 2.3.1 North America Syndromic Diagnostic Test Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Syndromic Diagnostic Test Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Syndromic Diagnostic Test Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Syndromic Diagnostic Test Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Syndromic Diagnostic Test Market Size Breakdown by Type (2021-2026)
3 Syndromic Diagnostic Test Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Laboratory
- 3.1.3 Research Institution
- 3.1.4 Others
- 3.2 Global Syndromic Diagnostic Test Market Size by Application
- 3.2.1 Global Syndromic Diagnostic Test Market Size Overview by Application (2021-2032)
- 3.2.2 Global Syndromic Diagnostic Test Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Syndromic Diagnostic Test Market Size Forecasted by Application (2027-2032)
- 3.3 Global Syndromic Diagnostic Test Market Size by Regions
- 3.3.1 North America Syndromic Diagnostic Test Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Syndromic Diagnostic Test Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Syndromic Diagnostic Test Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Syndromic Diagnostic Test Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Syndromic Diagnostic Test Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Syndromic Diagnostic Test Industry Trends
- 4.2 Syndromic Diagnostic Test Industry Drivers
- 4.3 Syndromic Diagnostic Test Industry Opportunities and Challenges
- 4.4 Syndromic Diagnostic Test Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Syndromic Diagnostic Test Revenue (2021-2026)
- 5.2 Global Syndromic Diagnostic Test Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Syndromic Diagnostic Test Key Company Headquarters & Area Served
- 5.4 Global Syndromic Diagnostic Test Company, Product Type & Application
- 5.5 Global Syndromic Diagnostic Test Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Syndromic Diagnostic Test Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Syndromic Diagnostic Test Players Market Share by Revenue in 2025
- 5.6.3 2025 Syndromic Diagnostic Test Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Syndromic Diagnostic Test Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Hologic
- 6.2.1 Hologic Company Information
- 6.2.2 Hologic Business Overview
- 6.2.3 Hologic Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Hologic Syndromic Diagnostic Test Product Portfolio
- 6.2.5 Hologic Recent Developments
- 6.3 Applied BioCode
- 6.3.1 Applied BioCode Company Information
- 6.3.2 Applied BioCode Business Overview
- 6.3.3 Applied BioCode Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Applied BioCode Syndromic Diagnostic Test Product Portfolio
- 6.3.5 Applied BioCode Recent Developments
- 6.4 Danaher
- 6.4.1 Danaher Company Information
- 6.4.2 Danaher Business Overview
- 6.4.3 Danaher Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Danaher Syndromic Diagnostic Test Product Portfolio
- 6.4.5 Danaher Recent Developments
- 6.5 Diagenode
- 6.5.1 Diagenode Company Information
- 6.5.2 Diagenode Business Overview
- 6.5.3 Diagenode Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Diagenode Syndromic Diagnostic Test Product Portfolio
- 6.5.5 Diagenode Recent Developments
- 6.6 Curetis
- 6.6.1 Curetis Company Information
- 6.6.2 Curetis Business Overview
- 6.6.3 Curetis Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Curetis Syndromic Diagnostic Test Product Portfolio
- 6.6.5 Curetis Recent Developments
- 6.7 Bio-Rad
- 6.7.1 Bio-Rad Company Information
- 6.7.2 Bio-Rad Business Overview
- 6.7.3 Bio-Rad Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bio-Rad Syndromic Diagnostic Test Product Portfolio
- 6.7.5 Bio-Rad Recent Developments
- 6.8 DiaSorin
- 6.8.1 DiaSorin Company Information
- 6.8.2 DiaSorin Business Overview
- 6.8.3 DiaSorin Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 DiaSorin Syndromic Diagnostic Test Product Portfolio
- 6.8.5 DiaSorin Recent Developments
- 6.9 bioMérieux
- 6.9.1 bioMérieux Company Information
- 6.9.2 bioMérieux Business Overview
- 6.9.3 bioMérieux Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 bioMérieux Syndromic Diagnostic Test Product Portfolio
- 6.9.5 bioMérieux Recent Developments
- 6.10 QIAGEN
- 6.10.1 QIAGEN Company Information
- 6.10.2 QIAGEN Business Overview
- 6.10.3 QIAGEN Syndromic Diagnostic Test Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 QIAGEN Syndromic Diagnostic Test Product Portfolio
- 6.10.5 QIAGEN Recent Developments
7 North America
- 7.1 North America Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 7.3 North America Syndromic Diagnostic Test Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 8.3 Europe Syndromic Diagnostic Test Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Syndromic Diagnostic Test Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 10.3 South America Syndromic Diagnostic Test Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Syndromic Diagnostic Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Syndromic Diagnostic Test Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst